Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: 4 year, single-center, retrospective study

被引：0
|
作者：
Shin, J. J. [1 ]
Seul, T. W. [1 ]
Park, H. W. [1 ]
Kim, H. Y. [1 ]
Son, S. W. [1 ]
机构：
[1] Korea Univ, Ansan Hosp, Ansan, Gyeonggi Do, South Korea
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
127
引用
下载
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [1] Drug survival analysis of dupilumab and associated predictors in patients with atopic dermatitis in South Korea: single-center, retrospective study
    Seul, Tae Woong
    Park, Hyun Woo
    Kim, Hyo Yoon
    Shin, Jung Jin
    Son, Sang Wook
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [2] DRUG SURVIVAL ANALYSIS OF DUPILUMAB AND ASSOCIATED PREDICTORS IN PATIENTS WITH ATOPIC DERMATITIS IN SOUTH KOREA: 4 YEARS, SINGLE-CENTER, RETROSPECTIVE STUDY
    Seul, Tae Woong
    Park, Hyun Woo
    Kim, Hyo Yoon
    Shin, Jung Jin
    Son, Sang Wook
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 23 - 23
  • [3] Dupilumab for atopic dermatitis treatment: A single-center retrospective study
    Yasar, Gulbin
    Bilgic, Asli
    Yilmaz, Ertan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (01): : 12 - 16
  • [4] DRUG SURVIVAL ANALYSIS OF DUPILUMAB IN MODERATE TO SEVERE ATOPIC DERMATITIS PATIENTS: A RETROSPECTIVE STUDY
    Kang, Da Hyun
    Choi, Sang Min
    Kwon, Soon Hyo
    Lew, Bark Lynn
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 47 - 47
  • [5] Effectiveness of dupilumab in atopic dermatitis on the head and neck: a single-center study on 553 patients
    Perego, Gabriele
    Aromolo, Italo F.
    Barei, Francesca
    Valtellini, Luca
    Marzano, Angelo V.
    Ferrucci, Silvia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (08) : e178 - e179
  • [6] Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study
    Napolitano, Maddalena
    Mariano, Maria
    Cristaudo, Antonio
    Dastoli, Stefano
    Di Guida, Adriana
    De Lucia, Mario
    Guerrasio, Gianluca
    Nistico, Steven Paul
    Passante, Maria
    Pigliacelli, Flavia
    Fabbrocini, Gabriella
    Patruno, Cataldo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2670 - 2673
  • [7] The efficacy and safety of dupilumab for the treatment of atopic dermatitis among Chinese patients in clinical practice: A single-center retrospective study
    Li, Ying
    Lu, Jiajing
    Chen, Rongfen
    Wang, Yu
    Ding, Yangfeng
    Xu, Shuang
    Zou, Ying
    Yi, Xuemei
    Shi, Yuling
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [8] Real-world effectiveness and drug survival of dupilumab: A single-center retrospective analysis
    Brazil, Molly
    Topham, Christina
    Simpson, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB123 - AB123
  • [9] BASELINE CHARACTERISTICS OF PATIENTS WITH SEVERE ATOPIC DERMATITIS: A SINGLE-CENTER COHORT STUDY IN KOREA
    Lee, Dong Heon
    Park, So Yun
    Hong, Narang
    Kook, Hyung Don
    Jung, Hye Jung
    Park, Mi Youn
    Ahn, Jiyoung
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 42 - 42
  • [10] A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease
    Spencer, Elizabeth A.
    Dolinger, Michael T.
    Dubinsky, Marla C.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (04) : 1121 - 1124
12345